English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Relapsed gynecologic cancers are difficult to control in the pelvis, especially when surgery, chemotherapy and radiation treatments have already been administered. For this clinical scenario, stereotactic body radiation therapy has emerged as a meaningful treatment strategy. The new Vero stereotactic body radiation therapy system uses coplanar and noncoplanar radiation treatment beams with submillimeter precision to treat cancer targets. This study describes the initial clinical experience with Vero hybrid arc stereotactic ablative body radiation therapy to treat relapsed gynecologic cancers detected in the pelvis.

Hybrid Arc Stereotactic Ablative Body Radiation Therapy for Pelvic Relapse of Gynecologic Malignancies